H. Lee Moffitt Cancer Center and Research Institute: all 539 studies

Page 4 of 6. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.

• Early Supportive Care and Nutritional Support in Adults With Pancreatic CancerCompletedNCT05438927Not applicable
• "COACH" Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy BehaviorsActive, not recruitingNCT05434702
• Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of LifeCompletedNCT05379933Not applicable
• Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast CancerSuspendedNCT05378464Phase 1
• Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-freeCompletedNCT05362318Not applicable
• Exercise to Boost Response to Checkpoint Blockade ImmunotherapyActive, not recruitingNCT05358938Early Phase 1
• Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)TerminatedNCT05316116Early Phase 1
• Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell TransplantActive, not recruitingNCT05271630
• Preop fSRS for Resectable Brain MetastasesActive, not recruitingNCT05267587Phase 2
• First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate CancerActive, not recruitingNCT05189457Phase 2
• Binimetinib Plus Belinostat for Subjects With Metastatic Uveal MelanomaActive, not recruitingNCT05170334Phase 2
• Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative NeoplasmsTerminatedNCT05127174Phase 1
• Adaptive Radiation for Locally Advanced Rectal AdenocarcinomaActive, not recruitingNCT05108428Early Phase 1
• SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular CarcinomaTerminatedNCT05093608Phase 1
• Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut MicrobiomeCompletedNCT05083416Not applicable
• Using Aspirin to Improve Immunological Features of Ovarian TumorsSuspendedNCT05080946Early Phase 1
• Evaluating Stress Management Among Allogeneic HCT CaregiversCompletedNCT05078229Not applicable
• Study of Afatinib in Advanced Cutaneous Squamous Cell CarcinomaActive, not recruitingNCT05070403Phase 2
• Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer CenterCompletedNCT05065944
• Duvelisib in Combination With BMS-986345 in Lymphoid MalignancyCompletedNCT05065866Phase 1
• Clinical Trials Outreach & EducationCompletedNCT05064423Not applicable
• Screen to Save: NCI Colorectal Cancer Outreach & Screening InitiativeCompletedNCT05064410Not applicable
• Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast CancerCompletedNCT05064085Phase 1
• COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer PatientsCompletedNCT05054218
• Study to Develop a Group-Based E-Health Intervention for YA Cancer SurvivorsCompletedNCT05048316Not applicable
• Wet Heparinized Suction for Abdominal CancerWithdrawnNCT05041335Not applicable
• Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCTActive, not recruitingNCT05015426Phase 1
• Axitinib + Ipilimumab in Advanced MelanomaActive, not recruitingNCT04996823Phase 2
• CARES-HCV: Promoting Screening Uptake Among Diverse Baby BoomersCompletedNCT04980157
• Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery EmbolizationActive, not recruitingNCT04879940Phase 2
• Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma PatientsActive, not recruitingNCT04863885Phase 1/2
• Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESAActive, not recruitingNCT04798339Phase 1/2
• Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age AdultsCompletedNCT04766164
• Cryotherapy for GAVEWithdrawnNCT04760873Not applicable
• Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBCCompletedNCT04610671Phase 1
• Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLCTerminatedNCT04610658Phase 1
• Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast MassesCompletedNCT04604561
• Addressing Barriers to Palliative Care Use in Bladder CancerCompletedNCT04598724
• SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in FloridaCompletedNCT04596579
• Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal DiseaseActive, not recruitingNCT04588545Phase 1/2
• IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma PatientsActive, not recruitingNCT04562129Phase 2
• DASH INtervention to INvestigate the GutCompletedNCT04538482Not applicable
• Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for HealthActive, not recruitingNCT04464668
• Evolutionary Therapy for RhabdomyosarcomaActive, not recruitingNCT04388839Phase 2
• Quality of Life Model for Older Patients With AMLActive, not recruitingNCT04380441
• Reducing Weight and Elevated Stress Levels Using Educational and Behavioral ToolsActive, not recruitingNCT04335799Not applicable
• Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported OutcomesCompletedNCT04319237
• Clinical Trial of Green Tea Catechins in Men on Active SurveillanceActive, not recruitingNCT04300855Phase 2
• Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the PancreasActive, not recruitingNCT04275557
• Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot StudyWithdrawnNCT04252612Early Phase 1
• Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAETerminatedNCT04150874Early Phase 1
• Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)CompletedNCT04092764Not applicable
• Mobile APP Utilization for Enhanced Post-Operative Nutritional RecoveryCompletedNCT04091165
• Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI TractCompletedNCT04069299
• Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for GliomasCompletedNCT04055688
• Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV GliomaTerminatedNCT03927274Early Phase 1
• Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung CancerActive, not recruitingNCT03923270Phase 1
• Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES)CompletedNCT03906110
• Prospective Study of Personalized Approach to Inpatient Patients With HyperglycemiaCompletedNCT03904199Early Phase 1
• Florida Pancreas Collaborative Next Generation BiobankActive, not recruitingNCT03851133
• Emotional Support Messages Following a Cancer DiagnosisCompletedNCT03840109
• Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain MetastasesCompletedNCT03807765Phase 1
• Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT03760523Phase 1
• IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid TumorsCompletedNCT03758781Phase 1
• Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate CancerWithdrawnNCT03748719Not applicable
• Avelumab With Radiotherapy in Patients With Leptomeningeal DiseaseCompletedNCT03719768Phase 1
• Total Tumor Mapping (TTM) for Resectable Pancreatic CancerWithdrawnNCT03718650Early Phase 1
• Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal CancerCompletedNCT03712943Phase 1
• Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer PatientsCompletedNCT03674138Not applicable
• Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1TerminatedNCT03630809Phase 2
• Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaActive, not recruitingNCT03628209Phase 1
• Immunonutrition to Reduce Toxicities in Non-Small Cell Lung CancerWithdrawnNCT03628144Phase 2
• SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical CancerActive, not recruitingNCT03614949Phase 2
• Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCActive, not recruitingNCT03611738Phase 1
• Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase InhibitorsActive, not recruitingNCT03610971Phase 2
• CD40-L Blockade for Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT03605927Phase 1
• Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current SmokersActive, not recruitingNCT03598309Phase 2
• Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant MelanomaActive, not recruitingNCT03543969Early Phase 1
• Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation TherapyCompletedNCT03543189Phase 1/2
• Improving Sleep in BMT SurvivorsCompletedNCT03537963Not applicable
• Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer ChemopreventionWithdrawnNCT03517995Phase 2
• Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate CancerActive, not recruitingNCT03511196Early Phase 1
• Study of Trametinib + Ceritinib in Patients With Unresectable MelanomaCompletedNCT03501368Phase 1
• Applying mHealth to Tobacco-related Health DisparitiesCompletedNCT03404596Early Phase 1
• HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast CancerCompletedNCT03387553Early Phase 1
• Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast CancerActive, not recruitingNCT03384914Phase 2
• IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell CarcinomaCompletedNCT03381183Phase 1
• PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer PatientWithdrawnNCT03295695Early Phase 1
• Biobank for African American Prostate Cancer Research in FloridaCompletedNCT03232411
• Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLCCompletedNCT03177291Phase 1
• Patient Navigation in the Adolescent and Young Adult (AYA) Cancer PopulationCompletedNCT03176576Not applicable
• Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening)CompletedNCT03078361Not applicable
• Increasing Access to Colorectal Cancer Testing (IACCT) for BlacksCompletedNCT03078348Not applicable
• Feasibility Study of Ultrasound Elastography Detecting Prostate CancerCompletedNCT03077126Not applicable
• Pilot Study of Regional Lung VentilationCompletedNCT03077113Not applicable
• Refining and Testing the Electronic Social Network Assessment Program (eSNAP)CompletedNCT03026699
• Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular CarcinomaWithdrawnNCT02989870Phase 1
• Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223CompletedNCT02981797
• Determinants of Age-Related Treatment Effectiveness in Ovarian CancerCompletedNCT02973750
• Therasphere for Unresectable Primary or Secondary Liver NeoplasiaNo longer availableNCT02960620

← H. Lee Moffitt Cancer Center and Research Institute overview and focus areas